张喆博士
生物药执行总监, 上海恒瑞医药有限公司
毕业于浙江大学医学院临床医学系，之后分别在中国医学科学院和比利时鲁汶大学获得硕士和基础医学博士学位。在鲁汶大学从事5年博士后研究之后，回国加入中科院生化细胞所。在进入工业界之前一直在国内外顶级的实验室从事细胞生物学、蛋白生化和分子生物学方面的研究，主要关注癌症及代谢性疾病的分子机理，承担了多个国家级学术项目的研究，在国内外核心刊物上发表近20篇学术论文。后转入工业界，负责或带领团队参与开发了大量大小分子创新药物，疾病领域覆盖肿瘤、自身免疫性疾病、代谢性疾病等，从早期靶点发现，机理探索验证到最终的分子开发都有丰富经验。目前就职于上海恒瑞医药公司，任生物药执行总监。
Dr. Zhe Zhang obtained her Ph.D. degree in Medical Sciences in Catholic University of Leuven, Belgium, after getting a Master degree in Chinese Academy of Medical Sciences, and her medical degree in Zhejiang University, China. After 5 years of post-doc fellowship in Catholic University of Leuven, she joined Institute Biochemistry and Cell Biology, Chinese Academy of Sciences. In her 20 years’ academic career, she mainly focused on molecular basis of human diseases (cancer & diabetes). She was in charge of multiple national research projects, authoring 20+ scientific publications in areas of cell biology and molecular biology.
Afterwards, she moved to industry and has become experienced in new drug targets identification & validation and lead molecules development. She has led her team to successfully deliver dozens of Pre-clinical Candidates in the area of oncology, immunology & metabolic diseases for both innovative small molecule drugs and biologics.
She is currently the Executive Director of Discovery Biology, Biologics in Jiangsu Hengrui Medicine Co., Ltd.
电话：+86 (0)512
地址：
Suzhou Dushu Lake Science and Education Innovation District
Suzhou Industrial Park
Suzhou
P.R.China
215123
生物药执行总监, 上海恒瑞医药有限公司
毕业于浙江大学医学院临床医学系，之后分别在中国医学科学院和比利时鲁汶大学获得硕士和基础医学博士学位。在鲁汶大学从事5年博士后研究之后，回国加入中科院生化细胞所。在进入工业界之前一直在国内外顶级的实验室从事细胞生物学、蛋白生化和分子生物学方面的研究，主要关注癌症及代谢性疾病的分子机理，承担了多个国家级学术项目的研究，在国内外核心刊物上发表近20篇学术论文。后转入工业界，负责或带领团队参与开发了大量大小分子创新药物，疾病领域覆盖肿瘤、自身免疫性疾病、代谢性疾病等，从早期靶点发现，机理探索验证到最终的分子开发都有丰富经验。目前就职于上海恒瑞医药公司，任生物药执行总监。
Dr. Zhe Zhang obtained her Ph.D. degree in Medical Sciences in Catholic University of Leuven, Belgium, after getting a Master degree in Chinese Academy of Medical Sciences, and her medical degree in Zhejiang University, China. After 5 years of post-doc fellowship in Catholic University of Leuven, she joined Institute Biochemistry and Cell Biology, Chinese Academy of Sciences. In her 20 years’ academic career, she mainly focused on molecular basis of human diseases (cancer & diabetes). She was in charge of multiple national research projects, authoring 20+ scientific publications in areas of cell biology and molecular biology.
Afterwards, she moved to industry and has become experienced in new drug targets identification & validation and lead molecules development. She has led her team to successfully deliver dozens of Pre-clinical Candidates in the area of oncology, immunology & metabolic diseases for both innovative small molecule drugs and biologics.
She is currently the Executive Director of Discovery Biology, Biologics in Jiangsu Hengrui Medicine Co., Ltd.
联系方式
电话：+86 (0)512
地址：Suzhou Dushu Lake Science and Education Innovation District
Suzhou Industrial Park
Suzhou
P.R.China
215123
